HB 172 (2024): relative to investigating potential redundancies between the prescription drug affordability board and existing state agency programs regarding prescription drug cost data.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA
“HB 172 (2024): relative to investigating potential redundancies between the prescription drug affordability board and existing state agency programs regarding prescription drug cost data.” Granite Record, https://graniterecord.org/bill/2024/hb172. Accessed 24 Oct. 2026.
APA
Granite Record. (n.d.). HB 172 (2024): relative to investigating potential redundancies between the prescription drug affordability board and existing state agency programs regarding prescription drug cost data. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2024/hb172
Chicago
Granite Record. “HB 172 (2024): relative to investigating potential redundancies between the prescription drug affordability board and existing state agency programs regarding prescription drug cost data.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2024/hb172.
BibTeX
@misc{bill-2024-hb172, title = {HB 172 (2024): relative to investigating potential redundancies between the prescription drug affordability board and existing state agency programs regarding prescription drug cost data.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2024/hb172}, note = {Accessed 24 Oct. 2026} }

HB 172 (2024)

relative to investigating potential redundancies between the prescription drug affordability board and existing state agency programs regarding prescription drug cost data.

  • Status: Killed
  • Term: 2023-2024
  • House committee: Commerce and Consumer Affairs
  • Subject: Public and Mental Health

The Story

It was introduced on January 4, 2023 and referred to the House Commerce and Consumer Affairs committee. The committee held a public hearing on January 26, 2023. The committee held work sessions on February 8, 2023 and March 8, 2023. The committee met in executive session on March 8, 2023 to vote on its recommendation. The committee retained the bill, holding it for further work rather than reporting it out this year. The committee held a work session on September 20, 2023. The committee met in executive session on November 8, 2023 to vote on its recommendation. The committee voted unanimously, 19–0, to recommend that the House kill it, and the report was placed on the consent calendar. On January 3, 2024 the House voted to kill it on a voice vote.

Sponsors

Hearings and Sessions

  • January 26, 2023, 10:00 AM: public hearing, House Commerce and Consumer Affairs, LOB 302-304
  • February 8, 2023, 10:45 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302-304
  • March 8, 2023, 10:00 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302-304
  • March 8, 2023, 1:15 PM: executive session, House Commerce and Consumer Affairs, LOB 302-304
  • September 20, 2023, 1:15 PM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302-304
  • November 8, 2023, 1:30 PM: executive session, House Commerce and Consumer Affairs, LOB 302-304

Votes

  • January 3, 2024, House: Inexpedient to Legislate — voice vote, passed

The Docket

  • January 4, 2023: Introduced 01/04/2023 and referred to Commerce and Consumer Affairs
  • January 26, 2023: Public Hearing: 01/26/2023 10:00 am LOB 302-304
  • February 8, 2023: Subcommittee Work Session: 02/08/2023 10:45 am LOB 302-304
  • March 8, 2023: Subcommittee Work Session: 03/08/2023 10:00 am LOB 302-304
  • March 8, 2023: Executive Session: 03/08/2023 01:15 pm LOB 302-304
  • March 13, 2023: Retained in Committee
  • September 6, 2023: ==CANCELLED== Subcommittee Work Session: 09/06/2023 01:15 pm LOB 302-304
  • September 20, 2023: Subcommittee Work Session: 09/20/2023 01:15 pm LOB 302-304
  • November 8, 2023: Executive Session: 11/08/2023 01:30 pm LOB 302-304
  • November 8, 2023: Committee Report: Inexpedient to Legislate HB172 11/08/2023 (Vote 19-0; CC)
  • November 15, 2023: ==CANCELLED== Executive Session: 11/15/2023 11:00 am LOB 302-304
  • January 3, 2024: Inexpedient to Legislate: MA VV 01/03/2024

From the General Court